Mechanisms of estrogens' dose-dependent neuroprotective and neurodamaging effects in experimental models of cerebral ischemia

International Journal of Molecular Sciences

Volumn 12, Issue 3, 2011, Pages 1533-1562

  Strom, Jakob O ^a   Theodorsson, Annette ^a,b   Theodorsson, Elvar ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Administration methods; Animal experiments; Cerebral ischemia; Estrogen; Stroke

Indexed keywords

ESTRADIOL; ESTROGEN; GROWTH FACTOR; NEUROPROTECTIVE AGENT;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; BRAIN DAMAGE; BRAIN ISCHEMIA; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MECHANISM; ENCEPHALITIS; EXCITOTOXICITY; EXPERIMENTAL MODEL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; REVIEW; SEX HORMONE DETERMINATION; ANIMAL; DISEASE MODEL; DRUG EFFECTS; METABOLISM; NERVE CELL; PATHOLOGY;

ANIMALIA; RATTUS;

ANIMALS; APOPTOSIS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGENS; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS;

EID: 79953323706     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12031533     Document Type: Review

References (219)

1. Hall, E.D.; Pazara, K.E.; Linseman, K.L. Sex differences in postischemic neuronal necrosis in gerbils. J. Cereb. Blood Flow Metab. 1991, 11, 292-298.
2. Simpkins, J.W.; Rajakumar, G.; Zhang, Y.Q.; Simpkins, C.E.; Greenwald, D.; Yu, C.J.; Bodor, N.; Day, A.L. Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J. Neurosurg. 1997, 87, 724-730.
3. Hurn, P.D.; Littleton-Kearney, M.T.; Kirsch, J.R.; Dharmarajan, A.M.; Traystman, R.J. Postischemic cerebral blood flow recovery in the female: Effect of 17beta-estradiol. J. Cereb. Blood Flow Metab. 1995, 15, 666-672.
4. Lobo, R.A. The risk of stroke in postmenopausal women receiving hormonal therapy. Climacteric 2009, 12 (Suppl 1), 81-85.
5. Rossouw, J.E.; Anderson, G.L.; Prentice, R.L.; LaCroix, A.Z.; Kooperberg, C.; Stefanick, M.L.; Jackson, R.D.; Beresford, S.A.; Howard, B.V.; Johnson, K.C.; Kotchen, J.M.; Ockene, J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. Jama 2002, 288, 321-333.
6. Harukuni, I.; Hurn, P.D.; Crain, B.J. Deleterious effect of beta-estradiol in a rat model of transient forebrain ischemia. Brain Res. 2001, 900, 137-142.
7. Yong, Y.; Xie, H.J.; Zhang, Y.F.; Yang, Q.D.; Liao, D.F.; Yang, H.L.; Yan, P.K.; Liu, Z.J. 17beta-estradiol potentiates ischemia-reperfusion injury in diabetic ovariectomized female rats. Brain Res. 2005, 1054, 192-199.
8. Theodorsson, A.; Theodorsson, E.Estradiol increases brain lesions in the cortex and lateral striatum after transient occlusion of the middle cerebral artery in rats: No effect of ischemia on galanin in the stroke area but decreased levels in the hippocampus. Peptides 2005, 26, 2257-2264.
9. Gordon, K.B.; Macrae, I.M.; Carswell, H.V. Effects of 17beta-oestradiol on cerebral ischaemic damage and lipid peroxidation. Brain Res. 2005, 1036, 155-162.
10. Carswell, H.V.; Bingham, D.; Wallace, K.; Nilsen, M.; Graham, D.I.; Dominiczak, A.F.; Macrae, I.M. Differential effects of 17beta-estradiol upon stroke damage in stroke prone and normotensive rats. J. Cereb. Blood Flow Metab. 2004, 24, 298-304.
11. Bingham, D.; Macrae, I.M.; Carswell, H.V. Detrimental effects of 17beta-oestradiol after permanent middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 2005, 25, 414-420.
12. Liu, M.; Dziennis, S.; Hurn, P.D.; Alkayed, N.J. Mechanisms of gender-linked ischemic brain injury. Restor. Neurol. Neurosci. 2009, 27, 163-179.
13. Brown, C.M.; Suzuki, S.; Jelks, K.A.; Wise, P.M.Estradiol is a potent protective, restorative, and trophic factor after brain injury. Semin. Reprod. Med. 2009, 27, 240-249.
14. Suzuki, S.; Brown, C.M.; Wise, P.M. Neuroprotective effects of estrogens following ischemic stroke. Front. Neuroendocrinol. 2009, 30, 201-211.
15. Strom, J.O.; Theodorsson, A.; Theodorsson, E. Dose-related neuroprotective versus neurodamaging effects of estrogens in rat cerebral ischemia: A systematic analysis. J. Cereb. Blood Flow Metab. 2009, 29, 1359-1372.
16. Strom, J.O.; Theodorsson, E.; Holm, L.; Theodorsson, A. Different methods for administering 17beta-estradiol to ovariectomized rats result in opposite effects on ischemic brain damage. BMC Neurosci. 2010, 11, 39.
17. Strom, J.O.; Theodorsson, E.; Theodorsson, A. Order of magnitude differences between methods for maintaining physiological 17beta-oestradiol concentrations in ovariectomized rats. Scand. J. Clin. Lab. Invest. 2008, 68, 814-822.
18. Calabrese, E.J.; Baldwin, L.A. Hormesis: The dose-response revolution. Annu. Rev. Pharmacol. Toxicol. 2003, 43, 175-197.
19. Dziennis, S.; Jia, T.; Ronnekleiv, O.K.; Hurn, P.D.; Alkayed, N.J. Role of signal transducer and activator of transcription-3 in estradiol-mediated neuroprotection. J. Neurosci. 2007, 27, 7268-7274.
20. Schreihofer, D.A.; Do, K.D.; Schreihofer, A.M. High-soy diet decreases infarct size after permanent middle cerebral artery occlusion in female rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289, R103-108.
21. Rau, S.W.; Dubal, D.B.; Bottner, M.; Gerhold, L.M.; Wise, P.M. Estradiol attenuates programmed cell death after stroke-like injury. J. Neurosci. 2003, 23, 11420-11426.
22. He, Z.; He, Y.J.; Day, A.L.; Simpkins, J.W. Proestrus levels of estradiol during transient global cerebral ischemia improves the histological outcome of the hippocampal CA1 region: Perfusion-dependent and-independent mechanisms. J. Neurol. Sci. 2002, 193, 79-87.
23. Sandstrom, N.J.; Rowan, M.H.Acute pretreatment with estradiol protects against CA1 cell loss and spatial learning impairments resulting from transient global ischemia. Horm. Behav. 2007, 51, 335-345.
24. Pelligrino, D.A.; Santizo, R.; Baughman, V.L.; Wang, Q. Cerebral vasodilating capacity during forebrain ischemia: Effects of chronic estrogen depletion and repletion and the role of neuronal nitric oxide synthase. Neuroreport 1998, 9, 3285-3291.
25. Saleh, T.M.; Connell, B.J.; Legge, C.; Cribb, A.E. Estrogen attenuates neuronal excitability in the insular cortex following middle cerebral artery occlusion. Brain Res. 2004, 1018, 119-129.
26. Plamondon, H.; Morin, A.; Charron, C. Chronic 17beta-estradiol pretreatment and ischemia-induced hippocampal degeneration and memory impairments: A 6-month survival study. Horm. Behav. 2006, 50, 361-369.
27. Choi, Y.C.; Lee, J.H.; Hong, K.W.; Lee, K.S. 17Beta-estradiol prevents focal cerebral ischemic damages via activation of Akt and CREB in association with reduced PTEN phosphorylation in rats. Fundam. Clin. Pharmacol. 2004, 18, 547-557.
28. Yu, S.J.; Kim, J.R.; Lee, C.K.; Kim, J.H.; Kam, K.Y.; Hong, J.H.; Kang, S.G. Involvement of purα gene in neuroprotection effects of estrogen in rat ischemic brain model. Korean J. Genet. 2006, 28, 403-412.
29. Gulinello, M.; Lebesgue, D.; Jover-Mengual, T.; Zukin, R.S.; Etgen, A.M. Acute and chronic estradiol treatments reduce memory deficits induced by transient global ischemia in female rats. Horm. Behav. 2006, 49, 246-260.
30. Kii, N.; Adachi, N.; Liu, K.; Arai, T. Acute effects of 17beta-estradiol on oxidative stress in ischemic rat striatum. J. Neurosurg. Anesthesiol. 2005, 17, 27-32.
31. Littleton-Kearney, M.T.; Klaus, J.A.; Hurn, P.D.Effects of combined oral conjugated estrogens and medroxyprogesterone acetate on brain infarction size after experimental stroke in rat. J. Cereb. Blood Flow Metab. 2005, 25, 421-426.
32. Strom, J.O.; Theodorsson, A.; Theodorsson, E. Substantial discrepancies in 17beta-oestradiol concentrations obtained with three different commercial direct radioimmunoassay kits in rat sera. Scand. J. Clin. Lab. Invest. 2008, 68, 806-813.
33. Suzuki, S.; Gerhold, L.M.; Bottner, M.; Rau, S.W.; Dela Cruz, C.; Yang, E.; Zhu, H.; Yu, J.; Cashion, A.B.; Kindy, M.S.; Merchenthaler, I.; Gage, F.H.; Wise, P.M.Estradiol enhances neurogenesis following ischemic stroke through estrogen receptors alpha and beta. J. Comp. Neurol. 2007, 500, 1064-1075.
34. Simpkins, J.W.; Yi, K.D.; Yang, S.H. Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogens. Front. Neuroendocrinol. 2009, 30, 93-105.
35. Singer, C.A.; Rogers, K.L.; Strickland, T.M.; Dorsa, D.M. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci. Lett. 1996, 212, 13-16.
36. Weaver, C.E., Jr; Park-Chung, M.; Gibbs, T.T.; Farb, D.H. 17Beta-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res. 1997, 761, 338-341.
37. Carswell, H.V.; Macrae, I.M.; Farr, T.D. Complexities of oestrogen in stroke. Clin. Sci. (London) 2010, 118, 375-389.
38. Macrae, I.M.; Carswell, H.V. Oestrogen and stroke: The potential for harm as well as benefit. Biochem. Soc. Trans. 2006, 34, 1362-1365.
39. Duckles, S.P.; Krause, D.N. Cerebrovascular effects of oestrogen: Multiplicity of action. Clin. Exp. Pharmacol. Physiol. 2007, 34, 801-808.
40. Simpkins, J.W.; Singh, M. More than a decade of estrogen neuroprotection. Alzheimers Dement. 2008, 4, S131-136.
41. Lebesgue, D.; Chevaleyre, V.; Zukin, R.S.; Etgen, A.M. Estradiol rescues neurons from global ischemia-induced cell death: Multiple cellular pathways of neuroprotection. Steroids 2009, 74, 555-561.
42. Arnold, S.; Beyer, C. Neuroprotection by estrogen in the brain: The mitochondrial compartment as presumed therapeutic target. J. Neurochem. 2009, 110, 1-11.
43. Sherwin, B.B. Estrogen therapy: Is time of initiation critical for neuroprotection? Nat. Rev. Endocrinol. 2009, 5, 620-627.
44. Fujimura, M.; Tominaga, T.; Chan, P.H. Neuroprotective effect of an antioxidant in ischemic brain injury: Involvement of neuronal apoptosis. Neurocrit. Care 2005, 2, 59-66.
45. Behl, C.; Skutella, T.; Lezoualc'h, F.; Post, A.; Widmann, M.; Newton, C.J.; Holsboer, F. Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Mol. Pharmacol. 1997, 51, 535-541.
46. Culmsee, C.; Vedder, H.; Ravati, A.; Junker, V.; Otto, D.; Ahlemeyer, B.; Krieg, J.C.; Krieglstein, J.Neuroprotection by estrogens in a mouse model of focal cerebral ischemia and in cultured neurons: Evidence for a receptor-independent antioxidative mechanism. J. Cereb. Blood Flow Metab. 1999, 19, 1263-1269.
47. Vedder, H.; Anthes, N.; Stumm, G.; Wurz, C.; Behl, C.; Krieg, J.C. Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system. J. Neurochem. 1999, 72, 2531-2538.
48. Ayres, S.; Abplanalp, W.; Liu, J.H.; Subbiah, M.T.Mechanisms involved in the protective effect of estradiol-17beta on lipid peroxidation and DNA damage. Am. J. Physiol. 1998, 274, E1002-1008.
49. Rattanajarasroj, S.; Unchern, S. Comparable attenuation of Abeta(25-35)-induced neurotoxicity by quercitrin and 17beta-estradiol in cultured rat hippocampal neurons. Neurochem. Res. 2010, 35, 1196-1205.
50. Wang, X.; Dykens, J.A.; Perez, E.; Liu, R.; Yang, S.; Covey, D.F.; Simpkins, J.W. Neuroprotective effects of 17beta-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells. Mol. Pharmacol. 2006, 70, 395-404.
51. Keller, J.N.; Germeyer, A.; Begley, J.G.; Mattson, M.P. 17Beta-estradiol attenuates oxidative impairment of synaptic Na+/K+-ATPase activity, glucose transport, and glutamate transport induced by amyloid beta-peptide and iron. J. Neurosci. Res. 1997, 50, 522-530.
52. Prokai, L.; Simpkins, J.W. Structure-nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds. Pharmacol. Ther. 2007, 114, 1-12.
53. Behl, C.; Widmann, M.; Trapp, T.; Holsboer, F. 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 1995, 216, 473-482.
54. Bonnefont, A.B.; Munoz, F.J.; Inestrosa, N.C. Estrogen protects neuronal cells from the cytotoxicity induced by acetylcholinesterase-amyloid complexes. FEBS Lett. 1998, 441, 220-224.
55. Prokai, L.; Prokai-Tatrai, K.; Perjesi, P.; Zharikova, A.D.; Perez, E.J.; Liu, R.; Simpkins, J.W. Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc. Natl. Acad. Sci. USA 2003, 100, 11741-11746.
56. Prokai-Tatrai, K.; Perjesi, P.; Rivera-Portalatin, N.M.; Simpkins, J.W.; Prokai, L. Mechanistic investigations on the antioxidant action of a neuroprotective estrogen derivative. Steroids 2008, 73, 280-288.
57. Picazo, O.; Azcoitia, I.; Garcia-Segura, L.M. Neuroprotective and neurotoxic effects of estrogens. Brain Res. 2003, 990, 20-27.
58. Chen, C.; Hu, Q.; Yan, J.; Lei, J.; Qin, L.; Shi, X.; Luan, L.; Yang, L.; Wang, K.; Han, J.; Nanda, A.; Zhou, C. Multiple effects of 2ME2 and D609 on the cortical expression of HIF-1alpha and apoptotic genes in a middle cerebral artery occlusion-induced focal ischemia rat model. J. Neurochem. 2007, 102, 1831-1841.
59. Bruce-Keller, A.J.; Keeling, J.L.; Keller, J.N.; Huang, F.F.; Camondola, S.; Mattson, M.P. Antiinflammatory effects of estrogen on microglial activation. Endocrinology 2000, 141, 3646-3656.
60. Diwakar, L.; Kenchappa, R.S.; Annepu, J.; Ravindranath, V. Downregulation of glutaredoxin but not glutathione loss leads to mitochondrial dysfunction in female mice CNS: Implications in excitotoxicity. Neurochem. Int. 2007, 51, 37-46.
61. Schmidt, A.J.; Krieg, J.C.; Vedder, H. Differential effects of glucocorticoids and gonadal steroids on glutathione levels in neuronal and glial cell systems. J. Neurosci. Res. 2002, 67, 544-550.
62. Diwakar, L.; Kenchappa, R.S.; Annepu, J.; Saeed, U.; Sujanitha, R.; Ravindranath, V. Down-regulation of glutaredoxin by estrogen receptor antagonist renders female mice susceptible to excitatory amino acid mediated complex I inhibition in CNS. Brain Res. 2006, 1125, 176-184.
63. Urata, Y.; Ihara, Y.; Murata, H.; Goto, S.; Koji, T.; Yodoi, J.; Inoue, S.; Kondo, T. 17Beta-estradiol protects against oxidative stress-induced cell death through the glutathione/glutaredoxin-dependent redox regulation of Akt in myocardiac H9c2 cells. J. Biol. Chem. 2006, 281, 13092-13102.
64. Ozacmak, V.H.; Sayan, H. The effects of 17beta estradiol, 17alpha estradiol and progesterone on oxidative stress biomarkers in ovariectomized female rat brain subjected to global cerebral ischemia. Physiol. Res. 2009, 58, 909-912.
65. Gottipati, S.; Cammarata, P.R. Mitochondrial superoxide dismutase activation with 17 beta-estradiol-treated human lens epithelial cells. Mol. Vis. 2008, 14, 898-905.
66. Pedram, A.; Razandi, M.; Wallace, D.C.; Levin, E.R. Functional estrogen receptors in the mitochondria of breast cancer cells. Mol. Biol. Cell 2006, 17, 2125-2137.
67. Tripanichkul, W.; Sripanichkulchai, K.; Duce, J.A.; Finkelstein, D.I. 17Beta-estradiol reduces nitrotyrosine immunoreactivity and increases SOD1 and SOD2 immunoreactivity in nigral neurons in male mice following MPTP insult. Brain Res. 2007, 1164, 24-31.
68. Strehlow, K.; Rotter, S.; Wassmann, S.; Adam, O.; Grohe, C.; Laufs, K.; Bohm, M.; Nickenig, G. Modulation of antioxidant enzyme expression and function by estrogen. Circ. Res. 2003, 93, 170-177.
69. Nilsen, J.; Irwin, R.W.; Gallaher, T.K.; Brinton, R.D. Estradiol in vivo regulation of brain mitochondrial proteome. J. Neurosci. 2007, 27, 14069-14077.
70. Irwin, R.W.; Yao, J.; Hamilton, R.T.; Cadenas, E.; Brinton, R.D.; Nilsen, J. Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology 2008, 149, 3167-3175.
71. Miller, A.A.; Drummond, G.R.; Mast, A.E.; Schmidt, H.H.; Sobey, C.G. Effect of gender on NADPH-oxidase activity, expression, and function in the cerebral circulation: Role of estrogen. Stroke 2007, 38, 2142-2149.
72. Zhang, Q.G.; Raz, L.; Wang, R.; Han, D.; De Sevilla, L.; Yang, F.; Vadlamudi, R.K.; Brann, D.W. Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. J. Neurosci. 2009, 29, 13823-13836.
73. Kumar, S.; Lata, K.; Mukhopadhyay, S.; Mukherjee, T.K. Role of estrogen receptors in pro-oxidative and anti-oxidative actions of estrogens: A perspective. Biochim. Biophys. Acta 2010, 1800, 1127-1135.
74. Sastre-Serra, J.; Valle, A.; Company, M.M.; Garau, I.; Oliver, J.; Roca, P. Estrogen down-regulates uncoupling proteins and increases oxidative stress in breast cancer. Free Radic. Biol. Med. 2010, 48, 506-512.
75. Felty, Q.; Xiong, W.C.; Sun, D.; Sarkar, S.; Singh, K.P.; Parkash, J.; Roy, D. Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers. Biochemistry 2005, 44, 6900-6909.
76. Rempel, M.A.; Hester, B.; Deharo, H.; Hong, H.; Wang, Y.; Schlenk, D. Effects of 17beta-estradiol, and its metabolite, 4-hydroxyestradiol on fertilization, embryo development and oxidative DNA damage in sand dollar (Dendraster excentricus) sperm. Sci. Total Environ. 2009, 407, 2209-2215.
77. Symonds, D.A.; Merchenthaler, I.; Flaws, J.A. Methoxychlor and estradiol induce oxidative stress DNA damage in the mouse ovarian surface epithelium. Toxicol. Sci. 2008, 105, 182-187.
78. Pajovic, S.B.; Saicic, Z.S.; Spasic, M.B.; Petrovic, V.M. The effect of ovarian hormones on antioxidant enzyme activities in the brain of male rats. Physiol. Res. 2003, 52, 189-194.
79. Genc S.; Gurdol, F.; Oner-Iyidogan, Y.; Suzme, R. Acute effects of estradiol and of diethylstilbestrol: Pro- or antioxidant potential? Res. Commun. Mol. Pathol. Pharmacol. 1999, 105, 253-261.
80. Ting, C.M.; Lee, Y.M.; Wong, C.K.; Wong, A.S.; Lung, H.L.; Lung, M.L.; Lo, K.W.; Wong, R.N.; Mak, N.K. 2-Methoxyestradiol induces endoreduplication through the induction of mitochondrial oxidative stress and the activation of MAPK signaling pathways. Biochem. Pharmacol. 2010, 79, 825-841.
81. Park, S.A.; Na, H.K.; Kim, E.H.; Cha, Y.N.; Surh, Y.J.4-hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IkappaB kinase: potential role of reactive oxygen species. Cancer Res. 2009, 69, 2416-2424.
82. She, M.R.; Li, J.G.; Guo, K.Y.; Lin, W.; Du, X.; Niu, X.Q. Requirement of reactive oxygen species generation in apoptosis of leukemia cells induced by 2-methoxyestradiol. Acta Pharmacol. Sin. 2007, 28, 1037-1044.
83. Jin, R.; Yang, G.; Li, G. Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells. J. Leukoc. Biol. 2010, 87, 779-789.
84. Barone, F.C.; Arvin, B.; White, R.F.; Miller, A.; Webb, C.L.; Willette, R.N.; Lysko, P.G.; Feuerstein, G.Z. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 1997, 28, 1233-1244.
85. Yamasaki, Y.; Matsuura, N.; Shozuhara, H.; Onodera, H.; Itoyama, Y.; Kogure, K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 1995, 26, 676-680; discussion 681.
86. Czlonkowska, A.; Ciesielska, A.; Gromadzka, G.; Kurkowska-Jastrzebska, I. Gender differences in neurological disease: Role of estrogens and cytokines. Endocrine 2006, 29, 243-256.
87. Mulcahy, N.J.; Ross, J.; Rothwell, N.J.; Loddick, S.A. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br. J. Pharmacol. 2003, 140, 471-476.
88. Relton, J.K.; Martin, D.; Thompson, R.C.; Russell, D.A. Peripheral administration of interleukin-1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Exp. Neurol. 1996, 138, 206-213.
89. Nawashiro, H.; Martin, D.; Hallenbeck, J.M.Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J. Cereb. Blood Flow Metab. 1997, 17, 229-232.
90. Martin-Villalba, A.; Hahne, M.; Kleber, S.; Vogel, J.; Falk, W.; Schenkel, J.; Krammer, P.H. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ. 2001, 8, 679-686.
91. Loddick, S.A.; Rothwell, N.J. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 1996, 16, 932-940.
92. Santizo, R.A.; Anderson, S.; Ye, S.; Koenig, H.M.; Pelligrino, D.A. Effects of estrogen on leukocyte adhesion after transient forebrain ischemia. Stroke 2000, 31, 2231-2235.
93. Mori, M.; Tsukahara, F.; Yoshioka, T.; Irie, K.; Ohta, H. Suppression by 17beta-estradiol of monocyte adhesion to vascular endothelial cells is mediated by estrogen receptors. Life Sci. 2004, 75, 599-609.
94. Nathan, L.; Pervin, S.; Singh, R.; Rosenfeld, M.; Chaudhuri, G. Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: Possible mechanisms for gender differences in atherosclerosis. Circ. Res. 1999, 85, 377-385.
95. Suzuki, S.; Brown, C.M.; Dela Cruz, C.D.; Yang, E.; Bridwell, D.A.; Wise, P.M.Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc. Natl. Acad. Sci. USA 2007, 104, 6013-6018.
96. Chiappetta, O.; Gliozzi, M.; Siviglia, E.; Amantea, D.; Morrone, L.A.; Berliocchi, L.; Bagetta, G.; Corasaniti, M.T. Evidence to implicate early modulation of interleukin-1beta expression in the neuroprotection afforded by 17beta-estradiol in male rats undergone transient middle cerebral artery occlusion. Int. Rev. Neurobiol. 2007, 82, 357-372.
97. Nordell, V.L.; Scarborough, M.M.; Buchanan, A.K.; Sohrabji, F. Differential effects of estrogen in the injured forebrain of young adult and reproductive senescent animals. Neurobiol. Aging 2003, 24, 733-743.
98. Tenenbaum, M.; Azab, A.N.; Kaplanski, J. Effects of estrogen against LPS-induced inflammation and toxicity in primary rat glial and neuronal cultures. J. Endotoxin Res. 2007, 13, 158-166.
99. Vegeto, E.; Bonincontro, C.; Pollio, G.; Sala, A.; Viappiani, S.; Nardi, F.; Brusadelli, A.; Viviani, B.; Ciana, P.; Maggi, A. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J. Neurosci. 2001, 21, 1809-1818.
100. Lewis, D.K.; Johnson, A.B.; Stohlgren, S.; Harms, A.; Sohrabji, F. Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats. J. Neuroimmunol. 2008, 195, 47-59.
101. Ray, P.; Ghosh, S.K.; Zhang, D.H.; Ray, A. Repression of interleukin-6 gene expression by 17beta-estradiol: Inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett. 1997, 409, 79-85.
102. Ospina, J.A.; Brevig, H.N.; Krause, D.N.; Duckles, S.P. Estrogen suppresses IL-1beta-mediated induction of COX-2 pathway in rat cerebral blood vessels. Am. J. Physiol. Heart Circ. Physiol. 2004, 286, H2010-2019.
103. Vegeto, E.; Belcredito, S.; Etteri, S.; Ghisletti, S.; Brusadelli, A.; Meda, C.; Krust, A.; Dupont, S.; Ciana, P.; Chambon, P.; Maggi, A. Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc. Natl. Acad. Sci. USA 2003, 100, 9614-9619.
104. Vegeto, E.; Benedusi, V.; Maggi, A. Estrogen anti-inflammatory activity in brain: A therapeutic opportunity for menopause and neurodegenerative diseases. Front. Neuroendocrinol. 2008, 29, 507-519.
105. Sunday, L.; Osuna, C.; Krause, D.N.; Duckles, S.P. Age alters cerebrovascular inflammation and effects of estrogen. Am. J. Physiol. Heart Circ. Physiol. 2007, 292, H2333-2340.
106. Srivastava, S.; Weitzmann, M.N.; Cenci, S.; Ross, F.P.; Adler, S.; Pacifici, R. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J. Clin. Invest. 1999, 104, 503-513.
107. Yatkin, E.; Bernoulli, J.; Talvitie, E.M.; Santti, R. Inflammation and epithelial alterations in rat prostate: Impact of the androgen to oestrogen ratio. Int. J. Androl. 2009, 32, 399-410.
108. Salem, M.L.; Hossain, M.S.; Nomoto, K. Mediation of the immunomodulatory effect of beta-estradiol on inflammatory responses by inhibition of recruitment and activation of inflammatory cells and their gene expression of TNF-alpha and IFN-gamma. Int. Arch. Allergy Immunol. 2000, 121, 235-245.
109. Wen, Y.; Yang, S.; Liu, R.; Perez, E.; Yi, K.D.; Koulen, P.; Simpkins, J.W. Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia. Brain Res. 2004, 1008, 147-154.
110. Lei, D.L.; Long, J.M.; Hengemihle, J.; O'Neill, J.; Manaye, K.F.; Ingram, D.K.; Mouton, P.R. Effects of estrogen and raloxifene on neuroglia number and morphology in the hippocampus of aged female mice. Neuroscience 2003, 121, 659-666.
111. Brown, C.M.; Dela Cruz, C.D.; Yang, E.; Wise, P.M.Inducible nitric oxide synthase and estradiol exhibit complementary neuroprotective roles after ischemic brain injury. Exp. Neurol. 2008, 210, 782-787.
112. Park, E.M.; Cho, S.; Frys, K.A.; Glickstein, S.B.; Zhou, P.; Anrather, J.; Ross, M.E.; Iadecola, C. Inducible nitric oxide synthase contributes to gender differences in ischemic brain injury. J. Cereb. Blood Flow Metab. 2006, 26, 392-401.
113. Xu, H.L.; Baughman, V.L.; Pelligrino, D.A. Estrogen replacement treatment in diabetic ovariectomized female rats potentiates postischemic leukocyte adhesion in cerebral venules. Stroke 2004, 35, 1974-1978.
114. Soucy, G.; Boivin, G.; Labrie, F.; Rivest, S. Estradiol is required for a proper immune response to bacterial and viral pathogens in the female brain. J. Immunol. 2005, 174, 6391-6398.
115. Johnson, A.B.; Sohrabji, F. Estrogen's effects on central and circulating immune cells vary with reproductive age. Neurobiol. Aging 2005, 26, 1365-1374.
116. Marriott, L.K.; Hauss-Wegrzyniak, B.; Benton, R.S.; Vraniak, P.D.; Wenk, G.L. Long-term estrogen therapy worsens the behavioral and neuropathological consequences of chronic brain inflammation. Behav. Neurosci. 2002, 116, 902-911.
117. O'Donnell, M.E.; Lam, T.I.; Tran, L.Q.; Foroutan, S.; Anderson, S.E. Estradiol reduces activity of the blood-brain barrier Na-K-Cl cotransporter and decreases edema formation in permanent middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 2006, 26, 1234-1249.
118. Krause, D.N.; Duckles, S.P.; Pelligrino, D.A. Influence of sex steroid hormones on cerebrovascular function. J. Appl. Physiol. 2006, 101, 1252-1261.
119. Wise, P.M.; Dubal, D.B. Estradiol protects against ischemic brain injury in middle-aged rats. Biol. Reprod. 2000, 63, 982-985.
120. Dubal, D.B.; Wise, P.M. Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology 2001, 142, 43-48.
121. Toung, T.J.; Chen, T.Y.; Littleton-Kearney, M.T.; Hurn, P.D.; Murphy, S.J.Effects of combined estrogen and progesterone on brain infarction in reproductively senescent female rats. J. Cereb. Blood Flow Metab. 2004, 24, 1160-1166.
122. Alkayed, N.J.; Murphy, S.J.; Traystman, R.J.; Hurn, P.D.; Miller, V.M. Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke 2000, 31, 161-168.
123. Toung, T.K.; Hurn, P.D.; Traystman, R.J.; Sieber, F.E. Estrogen decreases infarct size after temporary focal ischemia in a genetic model of type 1 diabetes mellitus. Stroke 2000, 31, 2701-2706.
124. Brouns, R.; De Deyn, P.P. The complexity of neurobiological processes in acute ischemic stroke. Clin. Neurol. Neurosurg. 2009, 111, 483-495.
125. Brann, D.W.; Zamorano, P.L.; Chorich, L.P.; Mahesh, V.B. Steroid hormone effects on NMDA receptor binding and NMDA receptor mRNA levels in the hypothalamus and cerebral cortex of the adult rat. Neuroendocrinology 1993, 58, 666-672.
126. Woolley, C.S.; Weiland, N.G.; McEwen, B.S.; Schwartzkroin, P.A. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: Correlation with dendritic spine density. J. Neurosci. 1997, 17, 1848-1859.
127. Weiland, N.G. Estradiol selectively regulates agonist binding sites on the N-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus. Endocrinology 1992, 131, 662-668.
128. Woolley, C.S.; McEwen, B.S.Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J. Comp. Neurol. 1993, 336, 293-306.
129. Woolley, C.S.; McEwen, B.S. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J. Neurosci. 1992, 12, 2549-2554.
130. Pozzo-Miller, L.D.; Inoue, T.; Murphy, D.D. Estradiol increases spine density and NMDA-dependent Ca2+ transients in spines of CA1 pyramidal neurons from hippocampal slices. J. Neurophysiol. 1999, 81, 1404-1411.
131. Buterbaugh, G.G.; Hudson, G.M. Estradiol replacement to female rats facilitates dorsal hippocampal but not ventral hippocampal kindled seizure acquisition. Exp. Neurol. 1991, 111, 55-64.
132. Warren, S.G.; Humphreys, A.G.; Juraska, J.M.; Greenough, W.T. LTP varies across the estrous cycle: enhanced synaptic plasticity in proestrus rats. Brain Res. 1995, 703, 26-30.
133. Foy, M.R.; Xu, J.; Xie, X.; Brinton, R.D.; Thompson, R.F.; Berger, T.W. 17Beta-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. J. Neurophysiol. 1999, 81, 925-929.
134. Teyler, T.J.; Vardaris, R.M.; Lewis, D.; Rawitch, A.B. Gonadal steroids: Effects on excitability of hippocampal pyramidal cells. Science 1980, 209, 1017-1018.
135. Smith, S.S.; Waterhouse, B.D.; Woodward, D.J. Sex steroid effects on extrahypothalamic CNS. I. Estrogen augments neuronal responsiveness to iontophoretically applied glutamate in the cerebellum. Brain Res. 1987, 422, 40-51.
136. Sato, K.; Matsuki, N.; Ohno, Y.; Nakazawa, K. Estrogens inhibit l-glutamate uptake activity of astrocytes via membrane estrogen receptor alpha. J. Neurochem. 2003, 86, 1498-1505.
137. Gu, Q.; Moss, R.L. 17Beta-Estradiol potentiates kainate-induced currents via activation of the cAMP cascade. J. Neurosci. 1996, 16, 3620-3629.
138. Johansen, F.F.; Jorgensen, M.B.; Diemer, N.H. Ischemic CA-1 pyramidal cell loss is prevented by preischemic colchicine destruction of dentate gyrus granule cells. Brain Res. 1986, 377, 344-347.
139. Onodera, H.; Sato, G.; Kogure, K. Lesions to Schaffer collaterals prevent ischemic death of CA1 pyramidal cells. Neurosci. Lett. 1986, 68, 169-174.
140. Wieloch, T.; Lindvall, O.; Blomqvist, P.; Gage, F.H. Evidence for amelioration of ischaemic neuronal damage in the hippocampal formation by lesions of the perforant path. Neurol. Res. 1985, 7, 24-26.
141. Ito, H.; Watanabe, Y.; Isshiki, A.; Uchino, H. Neuroprotective properties of propofol and midazolam, but not pentobarbital, on neuronal damage induced by forebrain ischemia, based on the GABAA receptors. Acta Anaesthesiol. Scand. 1999, 43, 153-162.
142. Schwartz-Bloom, R.D.; McDonough, K.J.; Chase, P.J.; Chadwick, L.E.; Inglefield, J.R.; Levin, E.D. Long-term neuroprotection by benzodiazepine full versus partial agonists after transient cerebral ischemia in the gerbil [corrected]. J. Cereb. Blood Flow Metab. 1998, 18, 548-558.
143. Goodman, Y.; Bruce, A.J.; Cheng, B.; Mattson, M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J. Neurochem. 1996, 66, 1836-1844.
144. Azcoitia, I.; Fernandez-Galaz, C.; Sierra, A.; Garcia-Segura, L.M. Gonadal hormones affect neuronal vulnerability to excitotoxin-induced degeneration. J. Neurocytol. 1999, 28, 699-710.
145. Mendelowitsch, A.; Ritz, M.F.; Ros, J.; Langemann, H.; Gratzl, O. 17beta-Estradiol reduces cortical lesion size in the glutamate excitotoxicity model by enhancing extracellular lactate: A new neuroprotective pathway. Brain Res. 2001, 901, 230-236.
146. DeGiorgio, L.A.; Attardi, B.; Shimizu, Y.; Ogata, M.; Volpe, B.T. 17Beta-estradiol treatment retards excitotoxic delayed degeneration in substantia nigra reticulata neurons. Brain Res. 2002, 936, 15-20.
147. Ritz, M.F.; Schmidt, P.; Mendelowitsch, A. 17Beta-estradiol effect on the extracellular concentration of amino acids in the glutamate excitotoxicity model in the rat. Neurochem. Res. 2002, 27, 1677-1683.
148. Ritz, M.F.; Schmidt, P.; Mendelowitsch, A. Acute effects of 17beta-estradiol on the extracellular concentration of excitatory amino acids and energy metabolites during transient cerebral ischemia in male rats. Brain Res. 2004, 1022, 157-163.
149. Zhang, H.; Xie, M.; Schools, G.P.; Feustel, P.F.; Wang, W.; Lei, T.; Kimelberg, H.K.; Zhou, M. Tamoxifen mediated estrogen receptor activation protects against early impairment of hippocampal neuron excitability in an oxygen/glucose deprivation brain slice ischemia model. Brain Res. 2009, 1247, 196-211.
150. Zhang, F.; Yin, W.; Chen, J. Apoptosis in cerebral ischemia: Executional and regulatory signaling mechanisms. Neurol. Res. 2004, 26, 835-845.
151. Niizuma, K.; Yoshioka, H.; Chen, H.; Kim, G.S.; Jung, J.E.; Katsu, M.; Okami, N.; Chan, P.H. Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochim. Biophys. Acta 2010, 1802, 92-99.
152. Broughton, B.R.; Reutens, D.C.; Sobey, C.G. Apoptotic mechanisms after cerebral ischemia. Stroke 2009, 40, e331-339.
153. Estus, S.; Tucker, H.M.; van Rooyen, C.; Wright, S.; Brigham, E.F.; Wogulis, M.; Rydel, R.E. Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant -apoptotic{norm of matrix} pattern of gene induction. J. Neurosci. 1997, 17, 7736-7745.
154. Estus, S.; Zaks, W.J.; Freeman, R.S.; Gruda, M.; Bravo, R.; Johnson, E.M., Jr. Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis. J. Cell Biol. 1994, 127, 1717-1727.
155. Rau, S.W.; Dubal, D.B.; Bottner, M.; Wise, P.M. Estradiol differentially regulates c-Fos after focal cerebral ischemia. J. Neurosci. 2003, 23, 10487-10494.
156. Kitagawa, K.; Matsumoto, M.; Tsujimoto, Y.; Ohtsuki, T.; Kuwabara, K.; Matsushita, K.; Yang, G.; Tanabe, H.; Martinou, J.C.; Hori, M.; Yanagihara, T. Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice. Stroke 1998, 29, 2616-2621.
157. Alkayed, N.J.; Goto, S.; Sugo, N.; Joh, H.D.; Klaus, J.; Crain, B.J.; Bernard, O.; Traystman, R.J.; Hurn, P.D. Estrogen and Bcl-2: Gene induction and effect of transgene in experimental stroke. J. Neurosci. 2001, 21, 7543-7550.
158. Krajewski, S.; Mai, J.K.; Krajewska, M.; Sikorska, M.; Mossakowski, M.J.; Reed, J.C. Upregulation of bax protein levels in neurons following cerebral ischemia. J. Neurosci. 1995, 15, 6364-6376.
159. Dubal, D.B.; Shughrue, P.J.; Wilson, M.E.; Merchenthaler, I.; Wise, P.M. Estradiol modulates bcl-2 in cerebral ischemia: A potential role for estrogen receptors. J. Neurosci. 1999, 19, 6385-6393.
160. Jover, T.; Tanaka, H.; Calderone, A.; Oguro, K.; Bennett, M.V.; Etgen, A.M.; Zukin, R.S. Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1. J. Neurosci. 2002, 22, 2115-2124.
161. Pike, C.J. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: Relevance to Alzheimer's disease. J. Neurochem. 1999, 72, 1552-1563.
162. Singer, C.A.; Rogers, K.L.; Dorsa, D.M. Modulation of Bcl-2 expression: A potential component of estrogen protection in NT2 neurons. Neuroreport 1998, 9, 2565-2568.
163. Kandouz, M.; Siromachkova, M.; Jacob, D.; Chretien Marquet, B.; Therwath, A.; Gompel, A. Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells. Int. J. Cancer 1996, 68, 120-125.
164. Yune, T.Y.; Park, H.G.; Lee, J.Y.; Oh, T.H. Estrogen-induced Bcl-2 expression after spinal cord injury is mediated through phosphoinositide-3-kinase/Akt-dependent CREB activation. J. Neurotrauma 2008, 25, 1121-1131.
165. Fan, L.; Pandey, S.C.; Cohen, R.S.Estrogen affects levels of Bcl-2 protein and mRNA in medial amygdala of ovariectomized rats. J. Neurosci. Res. 2008, 86, 3655-3664.
166. Sharma, K.; Mehra, R.D. Long-term administration of estrogen or tamoxifen to ovariectomized rats affords neuroprotection to hippocampal neurons by modulating the expression of Bcl-2 and Bax. Brain Res. 2008, 1204, 1-15.
167. Gollapudi, L.; Oblinger, M.M. Estrogen and NGF synergistically protect terminally differentiated, ERalpha-transfected PC12 cells from apoptosis. J. Neurosci. Res. 1999, 56, 471-481.
168. Honda, K.; Shimohama, S.; Sawada, H.; Kihara, T.; Nakamizo, T.; Shibasaki, H.; Akaike, A. Nongenomic antiapoptotic signal transduction by estrogen in cultured cortical neurons. J. Neurosci. Res. 2001, 64, 466-475.
169. Lee, S.Y.; Andoh, T.; Murphy, D.L.; Chiueh, C.C. 17Beta-estradiol activates ICI 182,780-sensitive estrogen receptors and cyclic GMP-dependent thioredoxin expression for neuroprotection. FASEB J. 2003, 17, 947-948.
170. Zhang, Y.; Bhavnani, B.R. Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release. BMC Neurosci. 2005, 6, 13.
171. Teixeira, C.; Reed, J.C.; Pratt, M.A. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 1995, 55, 3902-3907.
172. Funakoshi, T.; Yanai, A.; Shinoda, K.; Kawano, M.M.; Mizukami, Y. G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem. Biophys. Res. Commun. 2006, 346, 904-910.
173. Simpkins, J.W.; Wang, J.; Wang, X.; Perez, E.; Prokai, L.; Dykens, J.A. Mitochondria play a central role in estrogen-induced neuroprotection. Curr. Drug. Targets CNS Neurol. Disord. 2005, 4, 69-83.
174. Hansen, T.M.; Moss, A.J.; Brindle, N.P. Vascular endothelial growth factor and angiopoietins in neurovascular regeneration and protection following stroke. Curr. Neurovasc. Res. 2008, 5, 236-245.
175. Garcia-Segura, L.M.; Azcoitia, I.; DonCarlos, L.L. Neuroprotection by estradiol. Prog. Neurobiol. 2001, 63, 29-60.
176. Jones, K.J. Gonadal steroids as promoting factors in axonal regeneration. Brain Res. Bull. 1993, 30, 491-498.
177. Garcia-Segura, L.M.; Sanz, A.; Mendez, P. Cross-talk between IGF-I and estradiol in the brain: Focus on neuroprotection. Neuroendocrinology 2006, 84, 275-279.
178. Duenas, M.; Luquin, S.; Chowen, J.A.; Torres-Aleman, I.; Naftolin, F.; Garcia-Segura, L.M. Gonadal hormone regulation of insulin-like growth factor-I-like immunoreactivity in hypothalamic astroglia of developing and adult rats. Neuroendocrinology 1994, 59, 528-538.
179. Jezierski, M.K.; Sohrabji, F. Region- and peptide-specific regulation of the neurotrophins by estrogen. Brain Res. Mol. Brain Res. 2000, 85, 77-84.
180. Gibbs, R.B. Treatment with estrogen and progesterone affects relative levels of brain-derived neurotrophic factor mRNA and protein in different regions of the adult rat brain. Brain Res. 1999, 844, 20-27.
181. Sohrabji, F.; Miranda, R.C.; Toran-Allerand, C.D. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 1995, 92, 11110-11114.
182. Dhandapani, K.M.; Wade, F.M.; Mahesh, V.B.; Brann, D.W. Astrocyte-derived transforming growth factor-{beta} mediates the neuroprotective effects of 17{beta}-estradiol: Involvement of nonclassical genomic signaling pathways. Endocrinology 2005, 146, 2749-2759.
183. Mueller, M.D.; Vigne, J.L.; Minchenko, A.; Lebovic, D.I.; Leitman, D.C.; Taylor, R.N.Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc. Natl. Acad. Sci. USA 2000, 97, 10972-10977.
184. El-Ashry, D.; Chrysogelos, S.A.; Lippman, M.E.; Kern, F.G. Estrogen induction of TGF-alpha is mediated by an estrogen response element composed of two imperfect palindromes. J. Steroid Biochem. Mol. Biol. 1996, 59, 261-269.
185. Ferreira, A.; Caceres, A. Estrogen-enhanced neurite growth: Evidence for a selective induction of Tau and stable microtubules. J. Neurosci. 1991, 11, 392-400.
186. Singh, M.; Setalo G., Jr.; Guan, X.; Frail, D.E.; Toran-Allerand, C.D. Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice. J. Neurosci. 2000, 20, 1694-1700.
187. Mendez, P.; Azcoitia, I.; Garcia-Segura, L.M. Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain. Brain Res. Mol. Brain Res. 2003, 112, 170-176.
188. Quesada, A.; Micevych, P.E.Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions. J. Neurosci. Res. 2004, 75, 107-116.
189. Azcoitia, I.; Sierra, A.; Garcia-Segura, L.M. Neuroprotective effects of estradiol in the adult rat hippocampus: Interaction with insulin-like growth factor-I signalling. J. Neurosci. Res. 1999, 58, 815-822.
190. Jover-Mengual, T.; Zukin, R.S.; Etgen, A.M. MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia. Endocrinology 2007, 148, 1131-1143.
191. Traub, M.L.; De Butte-Smith, M.; Zukin, R.S.; Etgen, A.M. Oestradiol and insulin-like growth factor-1 reduce cell loss after global ischaemia in middle-aged female rats. J. Neuroendocrinol. 2009, 21, 1038-1044.
192. Shughrue, P.J.; Dorsa, D.M. Estrogen modulates the growth-associated protein GAP-43 (Neuromodulin) mRNA in the rat preoptic area and basal hypothalamus. Neuroendocrinology 1993, 57, 439-447.
193. Teter, B.; Harris-White, M.E.; Frautschy, S.A.; Cole, G.M. Role of apolipoprotein E and estrogen in mossy fiber sprouting in hippocampal slice cultures. Neuroscience 1999, 91, 1009-1016.
194. Scoville, S.A.; Bufton, S.M.; Liuzzi, F.J. Estrogen regulates neurofilament gene expression in adult female rat dorsal root ganglion neurons. Exp. Neurol. 1997, 146, 596-599.
195. Salom, J.B.; Burguete, M.C.; Perez-Asensio, F.J.; Torregrosa, G.; Alborch, E. Relaxant effects of 17-beta-estradiol in cerebral arteries through Ca(2+) entry inhibition. J. Cereb. Blood Flow Metab. 2001, 21, 422-429.
196. Ono, H.; Sasaki, Y.; Bamba, E.; Seki, J.; Giddings, J.C.; Yamamoto, J. Cerebral thrombosis and microcirculation of the rat during the oestrous cycle and after ovariectomy. Clin. Exp. Pharmacol. Physiol. 2002, 29, 73-78.
197. Ospina, J.A.; Krause, D.N.; Duckles, S.P. 17Beta-estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase. Stroke 2002, 33, 600-605.
198. Ospina, J.A.; Duckles, S.P.; Krause, D.N. 17Beta-estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilation. Am. J. Physiol. Heart Circ. Physiol. 2003, 285, H241-250.
199. Momoi, H.; Ikomi, F.; Ohhashi, T. Estrogen-induced augmentation of endothelium-dependent nitric oxide-mediated vasodilation in isolated rat cerebral small arteries. Jpn. J. Physiol. 2003, 53, 193-203.
200. Geary, G.G.; McNeill, A.M.; Ospina, J.A.; Krause, D.N.; Korach, K.S.; Duckles, S.P. Selected contribution: Cerebrovascular nos and cyclooxygenase are unaffected by estrogen in mice lacking estrogen receptor-alpha. J. Appl. Physiol. 2001, 91, 2391-2399; discussion 2389-2390.
201. McNeill, A.M.; Kim, N.; Duckles, S.P.; Krause, D.N.; Kontos, H.A. Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke 1999, 30, 2186-2190.
202. Geary, G.G.; Krause, D.N.; Duckles, S.P. Gonadal hormones affect diameter of male rat cerebral arteries through endothelium-dependent mechanisms. Am. J. Physiol. Heart Circ. Physiol. 2000, 279, H610-618.
203. Pelligrino, D.A.; Ye, S.; Tan, F.; Santizo, R.A.; Feinstein, D.L.; Wang, Q. Nitric-oxide-dependent pial arteriolar dilation in the female rat: Effects of chronic estrogen depletion and repletion. Biochem. Biophys. Res. Commun. 2000, 269, 165-171.
204. Stirone, C.; Chu, Y.; Sunday, L.; Duckles, S.P.; Krause, D.N. 17Beta-estradiol increases endothelial nitric oxide synthase mRNA copy number in cerebral blood vessels: Quantification by real-time polymerase chain reaction. Eur. J. Pharmacol. 2003, 478, 35-38.
205. Geary, G.G.; Krause, D.N.; Duckles, S.P. Estrogen reduces myogenic tone through a nitric oxide-dependent mechanism in rat cerebral arteries. Am. J. Physiol. 1998, 275, H292-300.
206. Geary, G.G.; Krause, D.N.; Duckles, S.P.Estrogen reduces mouse cerebral artery tone through endothelial NOS- and cyclooxygenase-dependent mechanisms. Am. J. Physiol. Heart Circ. Physiol. 2000, 279, H511-519.
207. Skarsgard, P.; van Breemen, C.; Laher, I. Estrogen regulates myogenic tone in pressurized cerebral arteries by enhanced basal release of nitric oxide. Am. J. Physiol. 1997, 273, H2248-2256.
208. Sobey C.G.; Weiler, J.M.; Boujaoude, M.; Woodman, O.L. Effect of short-term phytoestrogen treatment in male rats on nitric oxide-mediated responses of carotid and cerebral arteries: Comparison with 17beta-estradiol. J. Pharmacol. Exp. Ther. 2004, 310, 135-140.
209. Alkayed, N.J.; Harukuni, I.; Kimes, A.S.; London, E.D.; Traystman, R.J.; Hurn, P.D. Gender-linked brain injury in experimental stroke. Stroke 1998, 29, 159-165; discussion 166.
210. Krejza, J.; Siemkowicz, J.; Sawicka, M.; Szylak, A.; Kochanowicz, J.; Mariak, Z.; Lewko, J.; Spektor, V.; Babikian, V.; Bert, R. Oscillations of cerebrovascular resistance throughout the menstrual cycle in healthy women. Ultrasound Obstet. Gynecol. 2003, 22, 627-632.
211. McCullough, L.D.; Alkayed, N.J.; Traystman, R.J.; Williams, M.J.; Hurn, P.D. Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke. Stroke 2001, 32, 796-802.
212. Watanabe, Y.; Littleton-Kearney, M.T.; Traystman, R.J.; Hurn, P.D. Estrogen restores postischemic pial microvascular dilation. Am. J. Physiol. Heart Circ. Physiol. 2001, 281, H155-160.
213. Coma, M.; Guix, F.X.; Uribesalgo, I.; Espuna, G.; Sole, M.; Andreu, D.; Munoz, F.J. Lack of oestrogen protection in amyloid-mediated endothelial damage due to protein nitrotyrosination. Brain 2005, 128, 1613-1621.
214. Radi, R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. USA 2004, 101, 4003-4008.
215. Wang, Q.; Santizo, R.; Baughman, V.L.; Pelligrino, D.A.; Iadecola, C. Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats. Stroke 1999, 30, 630-637.
216. Carswell, H.V.; Anderson, N.H.; Morton, J.J.; McCulloch, J.; Dominiczak, A.F.; Macrae, I.M. Investigation of estrogen status and increased stroke sensitivity on cerebral blood flow after a focal ischemic insult. J. Cereb. Blood Flow Metab. 2000, 20, 931-936.
217. Shi, J.; Bui, J.D.; Yang, S.H.; He, Z.; Lucas, T.H.; Buckley, D.L.; Blackband, S.J.; King, M.A.; Day, A.L.; Simpkins, J.W. Estrogens decrease reperfusion-associated cortical ischemic damage: An MRI analysis in a transient focal ischemia model. Stroke 2001, 32, 987-992.
218. Rusa, R.; Alkayed, N.J.; Crain, B.J.; Traystman, R.J.; Kimes, A.S.; London, E.D.; Klaus, J.A.; Hurn, P.D. 17Beta-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke 1999, 30, 1665-1670.
219. Choi, J.M.; Romeo, R.D.; Brake, W.G.; Bethea, C.L.; Rosenwaks, Z.; McEwen, B.S. Estradiol increases pre- and post-synaptic proteins in the CA1 region of the hippocampus in female rhesus macaques (Macaca mulatta). Endocrinology 2003, 144, 4734-4738.